NovaBridge Biosciences annual gross margin
2021
NovaBridge Biosciences's gross margin was 47.25% for fiscal 2021.
View full NovaBridge Biosciences company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2021 | 2021-12-31 | 47.25% | — |
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review NovaBridge Biosciences source filings ↗